- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.17 BnMarket Estimate, 2026
$0.19 BnMarket Forecast, 2034
$0.44 BnCAGR, 2026–2034
11.32%Executive Summary: Middle East and Africa Precision Medicine Software Market
- Market Scope: Regional analysis of the Middle East and Africa (MEA) precision medicine software sector, detailing delivery modes, clinical applications, end-user frameworks, regulatory challenges, and country-level profiles.
- Market Valuation: Valued at USD 0.17 billion in 2025, reaching USD 0.19 billion in 2026, and projected to expand to USD 0.44 billion by 2034, growing at a robust CAGR of 11.32% from 2026 to 2034.
- Primary Growth Drivers: Rising adoption of IoMT healthcare technologies, increasing incidence of cancer and infectious diseases, technological advancements in next-generation sequencing and big data analytics, and expanding healthcare initiatives across regional hubs.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Delivery Mode | Web & Cloud-Based (dominated base year market share, driven by scalability, remote accessibility, and big data management) | Web & Cloud-Based (projected at a rapid growth rate, fueled by cloud storage integration and IoMT connectivity) |
| By Application | Oncology (accounted for the largest market share, backed by rising cancer incidence and targeted therapeutic requirements) | Pharmacogenomics & Rare Diseases (registering highest growth, driven by genomic sequencing and infectious disease tracking) |
| By End User | Healthcare Providers (captured major market share, supported by hospital adoption and personalized medicine demand) | Research Centers and Academic Institutes (projected at an extraordinary CAGR, propelled by initiatives like the African Genome Center) |
| By Country | GCC Countries & South Africa (market leaders with dominant share, backed by high healthcare expenditure and advanced infrastructure) | Turkey & UAE (key regional hubs driven by preventive medicine foundations, genomics investments, and clinical collaborations) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive environment characterized by international software vendors partnering with regional biotech firms, healthcare providers, and research centers to advance precision solutions.
Key Companies: SOPHiA GENETICS SA, Syapse, Inc., Foundation Medicine, Inc., 2bPrecise LLC, Fabric Genomics, Human Longevity, Inc., Translational Software, Inc., Gene42, Inc., IBM Watson Group, LifeOmic Health, LLC, Sunquest Information Systems Inc., Koninklijke Philips N.V., and Flatiron Health, Inc.
Download Free Sample Report
Middle East and Africa Precision Medicine Software Market Size
The Middle East and Africa precision medicine software market size was valued at USD 0.17 billion in 2025 and is anticipated to reach USD 0.19 billion in 2026 from USD 0.44 billion by 2034, growing at a CAGR of 11.32% during the forecast period from 2026 to 2034.
The Middle East and Africa market is expected to experience lucrative growth as IoMT healthcare technologies have increased in recent years. Pharmaceutical and Biotech Companies Attempt to Improve Precision Medicine and Medical Solutions in the region. Diagnostic companies attempt to improve the healthcare industry by adopting various technologies. The adoption of technologies such as next-generation sequencing and gene therapy creates opportunities for the growth of the precision medicine market in the region.
The increase in the incidence of cancer globally implies that anticancer therapies will be sought for its prevention and treatment, which is why it will have most of the therapeutic segment. Furthermore, big data companies are expected to grow for precision medicine technologies in the MEA region due to technological advancements.
In countries of the Middle East and Africa, personal expenditure accounts for almost half of total health expenditure. Therefore, many people have health insurance coverage, especially in rural areas and in the informal sector. African countries have underdeveloped drug supply chains and often face challenges in maintaining an adequate medical workforce. One of the most pressing and unique challenges facing African health systems is the shortage of properly trained health workers due to a lack of training programs, coupled with poor working conditions. These factors may hamper research and development in the market.
In African countries, the increasing prevalence of diseases such as HIV, malaria, tuberculosis, etc., justifies the use of precision drugs, which is expected to drive the market. Another factor that can be attributed to their growth is the ability of the people of the Middle East to pay for precision medicine. The growing demand for personalized medicine coupled with the adoption of the technology in the region is driving the growth of the precision medicine market.
In Turkey, cancer is one of the leading causes of death, followed by cardiovascular disease. In addition, the incidence rate of cancer is increasing dramatically, increasing the need for an advanced health system. For example, GLAB formed a foundation for preventive medicine related to inherited breast and colon cancer, further integrating precision medicine into the healthcare system. In addition, growing collaborations between companies are expected to boost the implementation of precision medicine. Hence, these developments are intended to create multiple growth opportunities for the precision medicine market in Turkey.
Likewise, there is a high growth potential for precision medicine in South Africa due to the increasing prevalence of infections and non-communicable diseases. In addition, several initiatives are underway to improve the availability of research data, complementing the growth of the genomics industry. For example, the African Genome Center is under construction, increasing the country's capacity to sequence the human genome. These developments would help accelerate the diagnosis and treatment of various diseases, including cancer, thereby supporting the precision medicine market in South Africa.
KEY MARKET PLAYERS
A few of the notable companies operating in the MEA precision medicine software market include SOPHiA GENETICS SA, Syapse, Inc., Foundation Medicine, Inc., 2bPrecise LLC, Fabric Genomics, Human Longevity, Inc., Translational Software, Inc., Gene42, Inc., IBM Watson Group, LifeOmic Health, LLC, Sunquest Information Systems Inc., Koninklijke Philips N.V., and Flatiron Health, Inc.
MARKET SEGMENTATION
The research report on the MEA precision medicine software market has been segmented and sub-segmented into the following categories.
By Delivery Mode
- Web & Cloud-Based
- On-Premise
By Application
- Oncology
- Pharmacogenomics
- Rare Diseases
- Other Applications
By End User
- Healthcare Providers
- Research Centers and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Other End Users
By Country
- KSA
- UAE
- Israel
- Rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- Rest of MEA